Abstract:

The HIV disease and its several antiviral agents have over the years been showing some associations with hypertension. While the HIV programme in sub sub-Saharan Africa including Nigeria, which is largely donor driven, focuses on the provision of HIV care only, the evolving trend of hypertension in this population goes unrecognised and neglected. The objective of the study was to establish the burden of hypertension in the HIV population as an evolving unrecognised comorbidity calling for attention. The variables of age, marital status and ethnicity were evaluated and appear to have some bearings with hypertension. This was a retrospective, descriptive study conducted at Modibbo Adama University Teaching Hospital, Yola, Adamawa Nigeria through a review of past medical records of HIV patients attending the infectious disease clinic during a 10-year period. The retrieved data were entered into and analysed using the IBM SPSS version 20.0 statistical software. Prevalence was expressed in percentage. Bivariate analysis was performed using the Chi-square test for association between socio demographics and hypertension status. A value of p < 0.05 was considered significant Twenty-two per cent (22.1%) of the study population were found to be hypertensive. Older age, marital status and ethnicity were found to be significantly associated with hypertension among the HIV population (p<0.001). This finding draws attention to the high burden of hypertension among people living with HIV/AIDS. Health policy makers and other stakeholders should therefore design and implement a wholistic HIV programme that incorporates care for non-communicable diseases such as hypertension.

References:

[1] Okubadejo NU, Ozoh OB, Ojo OO, Akinkugbe AO, Odeniyi IA, Adegoke O, et al. Prevalence of hypertension and blood pressure profile amongst urban-dwelling adults in Nigeria: a comparative analysis based on recent guideline recommendations. Clin Hypertens. 2019 Dec;25(1).

[2] Bigna JJ, Tankeu AT, Kaze AD, Noubiap JJ, Nansseu JR. Prevalence and incidence of hypertension in the global HIV-infected population: A systematic review and meta-analysis protocol. BMJ Open. 2017;7(10):1–5.

[3] National Research Council. The Continuing Epidemiological Transition in Sub-Saharan Africa [Internet]. The Continuing Epidemiological Transition in Sub-Saharan Africa. 2012. Available from: http://www.ncbi.nlm.nih.gov/books/NBK114514/.

[4] Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25.

[5] Dimala CA, Atashili J, Mbuagbaw JC, Wilfred A, Monekosso GL. Prevalence of hypertension in HIV/AIDS patients on highly active antiretroviral therapy (HAART) compared with HAART-naïve patients at the Limbe Regional Hospital, Cameroon. PLoS One. 2016;11(2):1–11.

[6] Korem M, Wallach T, Bursztyn M, Maayan S, Olshtain-Pops K. High prevalence of hypertension in ethiopian and non-ethiopian HIV-infected adults. Int J Hypertens. 2018;2018.

[7] Ssinabulya I, Kayima J, Longenecker C, Luwedde M, Semitala F, Kambugu A, et al. Subclinical atherosclerosis among HIV-infected adults attending HIV/AIDS care at two large ambulatory HIV clinics in Uganda. PLoS One. 2014;9(2):1–9.

[8] Santos J, Palacios R, Castells E, González M, Ruiz J, Márquez M. Impact of highly active antiretroviral therapy on blood pressure in patients with HIV infection. A prospective study in a cohort of naive patients. Nutrition and Metabolic Disorders in HIV Infection. 2004;3(2):421–4.

[9] Bloomfield GS, Hogan JW, Keter A, Holland TL, Sang E, Kimaiyo S, et al. Blood pressure level impacts risk of death among HIV seropositive adults in Kenya: A retrospective analysis of electronic health records. BMC Infect Dis. 2014;14(1):1–10.

[10] Disease CA. Inflammation, Atherosclerosis, and coronary artery disease. 2005;1685–95.

[11] Jung O, Bickel M, Ditting T, Rickerts V, Welk T, Helm EB, et al. Hypertension in HIV-1-infected patients and its impact on renal and cardiovascular integrity. Nephrology Dialysis Transplantation. 2004;19(9):2250–8.

[12] Hendrix Sloane, Misuraca, & Moore A. genetic changes NIH Public Access. Bone. 2013;23(1):1–7.

[13] Tien PC, Choi AI, Zolopa AR, Benson C, Tracy R, Scherzer R, et al. Inflammation and mortality in HIV-infected adults: Analysis of the FRAM study cohort. J Acquir Immune Defic Syndr (1988). 2010;55(3):316–22.

[14] Dubé MP, Lipshultz SE, Fichtenbaum CJ, Greenberg R, Schecter AD, Fisher SD. Effects of HIV Infection and Antiretroviral Therapy on the Heart and Vasculature. Circulation. 2008;118(2):36–40.

[15] Manner IW, Trøseid M, Oektedalen O, Baekken M, Os I. Low Nadir CD4 Cell Count Predicts Sustained Hypertension in HIV-Infected Individuals. J Clin Hypertens. 2013;15(2):101–6.

[16] Isomaa B, Almgren P, Tuom T. Cardiovascular Morbidity and Mortality. Diabetes Care. 2001;24(4):683–9.

[17] Crane HM, van Rompaey SE, Kitahata MM. Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy. Aids. 2006;20(7):1019–26.

[18] Farhangi MA, Keshavarz SA, Eshraghian M, Ostadrahimi A, Saboor-Yaraghi Dr. AA. White blood cell count in women: Relation to inflammatory biomarkers, haematological profiles, visceral adiposity, and other cardiovascular risk factors. J Health Popul Nutr. 2013;31(1):58–64.

[19] Rodolphe Thiébaut, Wafaa M El-Sadr, Nina Friis-Møller Rickenbach, Martin PR, Antonella, Monforte6 D, 7 LM, 8 EF, 9 OK, et al. Predictors of hypertension and changes of blood pressure in HIV-infected patients. Antivir Ther. 2005;10(7):811–23.

[20] Bosu WK, Aheto JMK, Zucchelli E, Reilly ST. Determinants of systemic hypertension in older adults in Africa: A systematic review. BMC Cardiovasc Disord. 2019;19(1).

[21] Girum T, Yasin F, Wasie A, Shumbej T, Bekele F, Zeleke B. The effect of “universal test and treat” program on HIV treatment outcomes and patient survival among a cohort of adults taking antiretroviral treatment (ART) in low-income settings of Gurage zone, South Ethiopia. AIDS Res Ther [Internet]. 2020;17(1):1–9. Available from: https://doi.org/10.1186/s12981-020-00274-3.

[22] Sample Size Calculator by Raosoft, Inc. [Internet]. Available from: http://www.raosoft.com/samplesize.html.

[23] Kwarisiima D, Balzer L, Heller D, Kotwani P, Chamie G, Clark T, et al. Population-based assessment of hypertension epidemiology and risk factors among HIV-positive and general populations in rural Uganda. PLoS One. 2016;11(5):1–11.

[24] Benzekri NA, Seydi M, Doye IN, Toure M, Sy MP, Kiviat NB, et al. Increasing prevalence of hypertension among HIV-positive and negative adults in Senegal, West Africa, 1994-2015. PLoS One. 2018;13(12):1–14.

[25] Peck RN, Shedafa R, Kalluvya S, Downs JA, Todd J, Suthanthiran M, et al. Hypertension, kidney disease, HIV, and antiretroviral therapy among Tanzanian adults: A cross-sectional study. BMC Med. 2014;12(1):1–11.

[26] Brennan AT, Jamieson L, Crowther NJ, Fox MP, George JA, Berry KM, et al. Prevalence, incidence, predictors, treatment, and control of hypertension among HIVpositive adults on antiretroviral treatment in public sector treatment programs in South Africa. PLoS One. 2018;13(10):1–19.

[27] Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. Journal of Clinical Endocrinology and Metabolism. 2007;92(7):2506–12.

[28] Tuoyire, D, & Ayeteh H. gender differences in the association between and hypertension in Ghana. J Biosoc Sci. 2019;51(3):313–34.

[29] Ramezankhani A, Azizi F, Hadaegh F. Associations of marital status with diabetes, hypertension, cardiovascular disease, and all-cause mortality: A long term follow-up study. PLoS One. 2019;14(4):1–15.

[30] Schwandt HM, Coresh J, Hindin MJ. Marital status, hypertension, coronary heart disease, diabetes, and death among African American women and men: Incidence and prevalence in the atherosclerosis risk in communities (ARIC) study participants. J Fam Issues. 2010;31(9):1211–29.